NCT03189394

Brief Summary

The proposed study is a randomized controlled intervention to reduce sexual risk for HIV among HIV-negative concordant and HIV discordant gay couples. There are three arms of the study: 1) the in-person experimental condition, PRIDE, 2) the online adaptation of the experimental condition, ePRIDE, and 3) the time- and attention-matched in-person control condition, Men's Health. Participants (N = 300 couples) will be randomized equally into one of the three study conditions and assessed via surveys at baseline and at 3-, 6- and 9-months after completion of the intervention sessions.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
600

participants targeted

Target at P75+ for phase_1 hiv-infections

Timeline
Completed

Started Jul 2017

Longer than P75 for phase_1 hiv-infections

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 5, 2017

Completed
2 months until next milestone

First Posted

Study publicly available on registry

June 16, 2017

Completed
15 days until next milestone

Study Start

First participant enrolled

July 1, 2017

Completed
4.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2021

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2022

Completed
Last Updated

December 11, 2018

Status Verified

December 1, 2018

Enrollment Period

4.2 years

First QC Date

April 5, 2017

Last Update Submit

December 10, 2018

Conditions

Keywords

HIVgay couplesrelationshipsdyads

Outcome Measures

Primary Outcomes (1)

  • Composite Risk for HIV (CR-HIV)

    The primary outcome variable will be a binary indicator of any HIV-risk (no vs. yes) in the past three months at baseline, 3, months, 6 months, and 9 months--based on a composite of self-reported sexual risk behavior (defined as CAS with a discordant or unknown HIV status partner as well as HIV-positive partner's ART interruption (defined as missing all ART doses over a 4-day period in the past three months 70) and suppressed viral load. We will rely on self-reports of viral load because sexual risk behavior is based on one's perception of one's own or the partners' viral load. Regular viral load tests will be emphasized in PRIDE and ePRIDE to encourage participants to be proactive about their lab work. Baseline, 3 months, 6 months, and 9 months will be assessed for change over time past the date of the intervention.

    9 months (baseline, 3, 6, and 9 month followups)

Study Arms (3)

PRIDE

EXPERIMENTAL

The in-person experimental condition, PRIDE, consists of in-person intervention activities that are scheduled over two Saturdays, back to back, approximately 3 hours each (6 hours total). This intervention consists of relationship-focused activities for couples to take part in together, focusing on relationship communication, dynamics, and sexual agreements.

Behavioral: PRIDE

ePRIDE

EXPERIMENTAL

ePRIDE is an online adaptation of the experimental condition, PRIDE, and consists of online intervention activities that are scheduled to be completed over two weeks, lasting approximately 6 hours total. This intervention consists of relationship-focused activities for couples to take part in together, focusing on relationship communication, dynamics, and sexual agreements, and is designed for couples to take together sitting side by side.

Behavioral: ePRIDE

Men's Health

ACTIVE COMPARATOR

Men's Health is the active comparator group. Participants in this group go through in-person intervention days, scheduled on Saturdays back to back, but differ from the PRIDE arm because this intervention does not focus on relationship dynamics. Instead, these two Saturday intervention days focus on general men's health, including heart health, cancer, and STDs.

Behavioral: Men's Health

Interventions

PRIDEBEHAVIORAL

A couples curriculum that is relationship-focused and in-person, aimed at helping to reduce the odds of a composite HIV risk variable among gay couples.

PRIDE
ePRIDEBEHAVIORAL

A couples curriculum that is relationship-focused and online, aimed at helping to reduce the odds of a composite HIV risk variable among gay couples.

ePRIDE
Men's HealthBEHAVIORAL

A men's health curriculum that is individualized and in-person, aimed at helping participants to focus on gay men's health.

Men's Health

Eligibility Criteria

Age18 Years+
Sexmale(Gender-based eligibility)
Gender Eligibility DetailsIdentify as biologically male and not transgender.
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years or older
  • speak English
  • live in the San Francisco Bay Area
  • have knowledge of their own and their partner's serostatus
  • are in a concordant HIV-negative or discordant relationship
  • at least one partner has had condomless anal sex (CAS) in the last three months
  • identify as biologically male and not transgender
  • in a committed relationship (defined as two men who are committed to each other above anyone else and have had sex with each other) with their primary male partner (who they will participate in the study with) for at least 3 months.

You may not qualify if:

  • under 18
  • do not speak English
  • do not live in the San Francisco Bay Area
  • do not know their own or their partner's HIV status
  • are in a relationship where both partners are HIV positive, neither partner reports CAS in the last three months
  • identifies as transgender
  • is of female sex
  • not in a current committed relationship for at least 3 months.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Center for Research and Education on Gender and Sexuaity (CREGS) At San Francisco State University

San Francisco, California, 94103, United States

RECRUITING

MeSH Terms

Conditions

HIV Infections

Interventions

Men's Health

Condition Hierarchy (Ancestors)

Blood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System Diseases

Intervention Hierarchy (Ancestors)

HealthPopulation Characteristics

Study Officials

  • Colleen Hoff, PhD

    CREGS, San Francisco State University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Cameron Michels, MA

CONTACT

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Participants will be aware that there are online and in-person aspects of the study as seen in the consent form, but will be randomized to a group and unaware of which arm they are in.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: On completion of the baseline survey and testing, couples will be randomized to one of the three arms of the study (PRIDE, ePRIDE, or Men's Health). Couples will be randomized in blocks with the block size randomly permuted via a SAS computer program based on a pseudo-random number generator. Each arm of the intervention will begin on the same date and run for two weeks. Couples randomized to ePRIDE will be sent a link on the same day that PRIDE and Men's Health sessions are scheduled and will have two weeks to complete the program.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 5, 2017

First Posted

June 16, 2017

Study Start

July 1, 2017

Primary Completion

September 1, 2021

Study Completion

September 1, 2022

Last Updated

December 11, 2018

Record last verified: 2018-12

Data Sharing

IPD Sharing
Will not share

Locations